MEDIACC receives advisory status for SME funding program

We are pleased to announce that MEDIACC has officially received the “advisory status within the meaning of the current funding guidelines for the promotion of business consultancies for SMEs” in the area of evidence generation for medical devices.
This enables us to support our customers as part of this important funding program. The program, which is co-financed by the Federal Ministry of Economics and Climate Protection and the European Social Fund Plus, aims to support small and medium-sized enterprises (SMEs) in overcoming entrepreneurial challenges.
For SMEs, our consulting covers all issues, in particular for the design of clinical trials of innovative products, including medical devices. This applies both to the generation of evidence as part of a conformity assessment process (CE certification), to extension of indications, to medical apps in the therapeutic or diagnostic sector, including DiGA and DiPA.
As a registered consultant with the Federal Office of Economics and Export Control (BAFA), we meet strict quality standards. We have an appropriate quality assurance tool and ensure that advice is carried out properly, in accordance with the guidelines.
The funding rate is either 50% and a maximum of 1,750 euros or 80% and a maximum of 2,800 euros of consulting costs. Companies can receive funding for two consultations per year.
Contact us to find out more about how we can help you submit your application and help you further develop your innovative product with this funding.
MEDIACC is at your side as a competent partner to overcome your business challenges together and strengthen your company for the future.
Demonstrate the medical benefits of your product
With our many years of experience and expertise, we offer effective solutions to show the medical benefits of your product.
From conception to implementation of preclinical and clinical studies, we support you with tailor-made services.
Find out how MEDIACC can help you get your products refunded.